Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-19 9:11 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 12,577,821 19.9% | 7,976,013 (+173.32%) | View |
| 2024-03-11 7:19 pm Unchanged | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 16% | 0 (Unchanged) | View |
| 2024-03-08 4:30 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 4,601,808 9.9% | 48,319 (+1.06%) | View |
| 2023-11-15 4:35 pm Unchanged | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 18.3% | 0 (Unchanged) | View |
| 2023-05-08 4:43 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 4,553,489 9.9% | 1,017,000 (+28.76%) | View |
| 2023-03-17 4:19 pm Purchase | 13D | BIOMX INC PHGE | OrbiMed Israel BioFund GP Limited Partnership | 3,536,489 10.5% | 1,245,999 (+54.40%) | View |
| 2023-01-05 4:31 pm Sale | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 19.7% | -49,869,729 (-95.65%) | View |
| 2022-07-01 5:20 pm Sale | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.6% | -3,027,545 (-19.68%) | View |
| 2021-06-28 5:24 pm Sale | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6% | -17,118,837 (-52.67%) | View |
| 2021-04-07 4:46 pm Unchanged | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.2% | 0 (Unchanged) | View |
| 2021-03-26 4:06 pm Purchase | 13D | CHEMOMAB THERAPEUTICS LTD CMMB | OrbiMed Israel BioFund GP Limited Partnership | 52,139,820 24.3% | 52,139,820 (New Position) | View |
| 2021-03-25 5:26 pm Unchanged | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.6% | 0 (Unchanged) | View |
| 2021-01-05 4:38 pm Unchanged | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 0.5% | 0 (Unchanged) | View |
| 2020-12-16 5:13 pm Purchase | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16% | 1,943,734 (+6.36%) | View |
| 2020-12-04 5:12 pm Sale | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 73,650 5.1% | -103,200 (-58.35%) | View |
| 2020-11-20 4:39 pm Unchanged | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 176,850 12.4% | 0 (Unchanged) | View |
| 2020-10-13 9:20 pm Purchase | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 176,850 14.1% | 176,850 (New Position) | View |
| 2020-08-18 4:35 pm Unchanged | 13D | NOVUS THERAPEUTICS INC NVUS | OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.4% | 0 (Unchanged) | View |
| 2020-07-29 1:38 pm Unchanged | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 21.4% | 0 (Unchanged) | View |
| 2020-05-14 5:25 pm Purchase | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT | OrbiMed Israel BioFund GP Limited Partnership | 30,559,521 27.3% | 30,559,521 (New Position) | View |